Centogene NV (FRA:39K) Net Issuance of Preferred Stock : €0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Centogene NV Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Centogene NV's net issuance of preferred for the three months ended in Jun. 2023 was €0.00 Mil. The number is 0, which means that Centogene NV has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Centogene NV's net issuance of preferred for the trailing twelve months (TTM) ended in Jun. 2023 was €0.00 Mil.

Centogene NV Net Issuance of Preferred Stock Historical Data

The historical data trend for Centogene NV's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centogene NV Net Issuance of Preferred Stock Chart

Centogene NV Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Centogene NV Quarterly Data
	Dec17	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Centogene NV Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Centogene NV Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Centogene NV's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Centogene NV (FRA:39K) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Centogene NV (FRA:39K) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

CNTG:USA 39K:Germany

Address

Am Strande 7, Rostock, MV, DEU, 18055

Website

https://www.centogene.com

Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.

Centogene NV (FRA:39K) Headlines

No Headlines